Epicardial adipose tissue, obesity, and the occurrence of atrial fibrillation: an overview of pathophysiology and treatment methods

JP Scarano Pereira, E Owen, A Martinino… - Expert Review of …, 2022 - Taylor & Francis
Introduction Obesity is a chronic disease, which has significant health consequences and is
a staggering burden to health care systems. Obesity can have harmful effects on the …

Views, experiences and contributory factors related to medication errors associated with direct oral anticoagulants: a qualitative study with physicians and nurses

A Al Rowily, N Aloudah, Z Jalal, MH Abutaleb… - International Journal of …, 2022 - Springer
Abstract Background Direct oral anticoagulants (DOACs) have become preferable for the
management of thromboembolic events. Recent publications have however identified high …

Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity

BL Erstad, JF Barletta - Annals of Pharmacotherapy, 2023 - journals.sagepub.com
Objective: The objective of the study was to discuss the controversies surrounding the use
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …

[HTML][HTML] Direct oral anticoagulation and severe obesity–One size fits all?

AC Fender, M Gawalko, D Dobrev - International Journal of …, 2021 - ncbi.nlm.nih.gov
Oral anticoagulation is obligatory in patients with atrial fibrillation (AF) to prevent
thromboembolic stroke. Direct direct oral anticoagulants (DOAC) exhibit improved safety …

The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis

S Elfar, SA Mahmoud, S Hamdi, AA Emad… - BMC Cardiovascular …, 2024 - Springer
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data

M Alalawneh, O Rachid, I Abdallah, A Mahfouz… - European Journal of …, 2023 - Springer
Purpose To investigate real-world prescribing trends and clinical outcomes based on body
mass index (BMI) categorization in patients who received rivaroxaban therapy. Methods This …

An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation

NN Shen, E Ferroni, CB Amidei… - Clinical and Applied …, 2023 - journals.sagepub.com
Introduction Off-label, under-, and overdosed direct oral anticoagulants (DOACs) are
commonly prescribed to patients with atrial fibrillation (AF), but real-world evidence on their …

Situación actual de los anticoagulantes orales de acción directa en atención primaria de España. Posicionamiento de SEMERGEN en 2023

J Polo-García, V Pallarés-Carratalá… - Medicina de Familia …, 2024 - Elsevier
La anticoagulación oral es clave para disminuir el riesgo de ictus en la fibrilación auricular.
Aunque clásicamente los antagonistas de la vitamina K (AVK) se han empleado para este …

[HTML][HTML] Recent highlights on thrombosis and hemostasis from the International Journal of Cardiology: Heart & Vasculature

AC Fender, D Dobrev - International Journal of Cardiology. Heart & …, 2022 - ncbi.nlm.nih.gov
2 finding was that DOAC use consistently led to lower bleeding rates than warfarin, with
comparable effects on cardiovascular risk and mortality, and that safety and efficacy was …

[HTML][HTML] Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial …

AC Fender, D Dobrev - International Journal of Cardiology. Heart & …, 2023 - ncbi.nlm.nih.gov
2 effective stroke prevention in AF are comprehensively discussed by Barnes et al.[13], who
reported from the global anticoagulation round table. A key message arising from the …